Treatment with Miltex for metastatic skin lesions in breast cancer
Moĭseenko, V.M.; Orlova, R.V.; Ermakova, N.A.; Protsenko, S.A.
Voprosy Onkologii 46(5): 600-603
2000
ISSN/ISBN: 0507-3758 PMID: 11202195 Document Number: 514987
Miltex (miltefosine) is a new antiproliferation drug comprising phospholipid ingredients. It is used for topical treatment of metastatic skin lesions in breast cancer. Clinical trials of the drug were conducted in 11 breast cancer patients resistant to standard therapy. Apparent therapeutic effect (partial regression) was registered in 27.3% (3/11). Moderate toxic effects were generally confined to skin itching (36.4%) and scaling (18.2%), erythema (18.2%), and paper skin (45.5%).